PDF) 2-Alkyl/alkenyl substituted pyridine C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as highly potent TRPV1 antagonists
Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry
![PDF) Corrigendum to “Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides” [Bioorg. Med. Chem. Lett. 26 (2016) 5867–5870]](https://i1.rgstatic.net/publication/318331613_Corrigendum_to_Synthesis_and_carbonic_anhydrase_inhibitory_properties_of_novel_chalcone_substituted_benzenesulfonamides_Bioorg_Med_Chem_Lett_26_2016_5867-5870/links/5e28005b92851c3aadcfb95e/largepreview.png "PDF) Corrigendum to “Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides” [Bioorg. Med. Chem. Lett. 26 (2016) 5867–5870]")
PDF) Corrigendum to “Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides” [Bioorg. Med. Chem. Lett. 26 (2016) 5867–5870]
Publications_2012
Bioorganic & Medicinal Chemistry Letters | Vol 16, Issue 6, Pages 1451-1758 (15 March 2006) | ScienceDirect.com by Elsevier
Development of Highly Potent and Selective Steroidal Inhibitors and Degraders of CDK8 | ACS Medicinal Chemistry Letters
CCHF | Publication
Bioorganic & Medicinal Chemistry Letters | Vol 28, Issue 14, Pages 2343-2576 (1 August 2018) | ScienceDirect.com by Elsevier
Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry
PROTAC Technology: Opportunities and Challenges | ACS Medicinal Chemistry Letters
Bioorganic & Medicinal Chemistry Letters | Journal | ScienceDirect.com by Elsevier
Bioorganic & Medicinal Chemistry Letters | Vol 26, Issue 15, Pages 3381-3830 (1 August 2016) | ScienceDirect.com by Elsevier
Dima Sabbah, Ph.D. PEER REVIEWED SCIENTIFIC ARTICLES (11SUBMITTED/ ACCEPTED/ PUBLISHED PEER REVIEWED ARTICLES) 1. Sweidan K.,
Writing Your Next Medicinal Chemistry Article: Journal Bibliometrics and Guiding Principles for Industrial Authors | Journal of Medicinal Chemistry
Bioorganic & Medicinal Chemistry Letters | Vol 23, Issue 1, Pages 1-382 (1 January 2013) | ScienceDirect.com by Elsevier
Fragment-to-Lead Medicinal Chemistry Publications in 2017 | Journal of Medicinal Chemistry
Targeting IRAK4 for Degradation with PROTACs | ACS Medicinal Chemistry Letters
Publications & Patents - The Trippier Lab
成果及论文 - 南华大学王震课题组
Bioorganic & Medicinal Chemistry Letters | Vol 30, Issue 17, 1 September 2020 | ScienceDirect.com by Elsevier
PDF) Design, synthesis, and preliminary biological evaluation of novel ethyl 1-(2 '-hydroxy-3 '-aroxypropyl)-3-aryl-1H-pyrazole-5-carboxylate
Bioorganic & Medicinal Chemistry Letters | Vol 26, Issue 1, Pages 1-240 (1 January 2016) | ScienceDirect.com by Elsevier
Corrigendum to “Novel purine-based fluoroaryl-1,2,3-triazoles as neuroprotecting agents: Synthesis, neuronal cell culture
Bioorganic
![PDF) Corrigendum to 'Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA' [Bioor. Med. Chem. Lett. 29/10 (2019) 1246–1255]](https://i1.rgstatic.net/publication/332830620_Corrigendum_to_'Synthesis_and_biological_evaluation_of_Doxorubicin-containing_conjugate_targeting_PSMA'_Bioor_Med_Chem_Lett_2910_2019_1246-1255/links/60084c9192851c13fe2413ca/largepreview.png "PDF) Corrigendum to 'Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA' [Bioor. Med. Chem. Lett. 29/10 (2019) 1246–1255]")
PDF) Corrigendum to 'Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA' [Bioor. Med. Chem. Lett. 29/10 (2019) 1246–1255]
